原发肾病类型与供者亲缘关系对活体供肾移植结局的影响:ANZDATA分析
该回顾性观察研究基于澳大利亚和新西兰透析与移植登记(ANZDATA)1998年1月1日至2018年12月31日期间5500例活体供肾移植受者,评估原发肾病类型和供者亲缘关系与移植结局的关联。结果显示主要单基因肾病(校正HR 0.58,P<0.001)和次要单基因肾病(校正HR 0.64,P<0.001)较其他原发肾病复发率降低,主要单基因肾病组移植物失败率亦降低(校正HR 0.86,P=0.04),供者亲缘关系与复发或移植物失败无关。
要点
- 主要单基因肾病与较低的肾病复发风险相关(校正HR 0.58,P<0.001)。
- 主要单基因肾病与较低的移植物失败风险相关(校正HR 0.86,P=0.04)。
- 供者亲缘关系与肾病复发及移植物失败均无显著关联。
核心结论
- 单基因原发肾病与较低的肾病复发率和移植物失败率相关。
- 供者亲缘关系与移植物结局无关。
- 这些结果或可为移植前咨询和活体供者选择提供参考。
研究设计与样本
- 回顾性观察研究,纳入1998年1月1日至2018年12月31日期间在澳大利亚和新西兰透析与移植登记(ANZDATA)中记录的活体供肾移植受者,共5500例。
- 暴露因素为原发肾病类型(根据疾病遗传度分为主要单基因、次要单基因或其他原发肾病)以及供者亲缘关系。
- 采用Kaplan-Meier分析和Cox比例风险回归生成原发肾病复发、移植物失败和死亡的风险比,并使用部分似然比检验考察原发肾病类型与供者亲缘关系对两项研究结局的交互作用。
主要发现
- 与其它原发肾病相比,主要单基因原发肾病与较低的肾病复发风险相关(校正HR 0.58,P<0.001),次要单基因原发肾病亦与较低的肾病复发风险相关(校正HR 0.64,P<0.001)。
- 与其它原发肾病相比,主要单基因原发肾病与较低的移植物失败风险相关(校正HR 0.86,P=0.04)。
- 供者亲缘关系与肾病复发及移植物失败均无显著关联。
- 原发肾病类型与供者亲缘关系对两项研究结局均未检测到交互作用。
临床怎么用
- 作者认为这些结果或可为移植前咨询和活体供者选择提供参考。
局限性
- 原发肾病类型可能存在错误分类。
- 原发肾病复发的确认可能不完整。
- 存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: There is limited information about the association between primary kidney disease and donor relatedness with transplant outcomes. This study addresses this gap by evaluating clinical outcomes after kidney transplantation in recipients of living donor kidneys as a function of primary kidney disease type and donor relatedness in Australia and New Zealand. STUDY DESIGN: Retrospective observational study. SETTING & PARTICIPANTS: Kidney transplant recipients who received allografts from living donors between January 1, 1998, and December 31, 2018, as recorded in the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA). EXPOSURES: Primary kidney disease type categorized as majority monogenic, minority monogenic, or other primary kidney disease based on disease heritability as well as donor relatedness. OUTCOME: Primary kidney disease recurrence, graft failure. ANALYTICAL APPROACH: Kaplan-Meier analysis and Cox proportion hazards regression to generate hazard ratios for primary kidney disease recurrence, allograft failure, and mortality. Partial likelihood ratio test was used to examine possible interactions between primary kidney disease type and donor relatedness for both study outcomes. RESULTS: Among 5,500 live donor kidney transplant recipients, majority monogenic (adjusted HR, 0.58, P<0.001) and minority monogenic primary kidney diseases (adjusted HR, 0.64, P<0.001) were associated with reduced primary kidney disease recurrence compared with other primary kidney diseases. Majority monogenic primary kidney disease was also associated with reduced allograft failure (adjusted HR, 0.86, P=0.04) compared with other primary kidney diseases. Donor relatedness was not associated with primary kidney disease recurrence nor graft failure. No interaction was detected between primary kidney disease type and donor relatedness for either study outcome. LIMITATIONS: Potential misclassification of primary kidney disease type, incomplete ascertainment of primary kidney disease recurrence, unmeasured confounding. CONCLUSIONS: Monogenic primary kidney disease is associated with lower rates of primary kidney disease recurrence and allograft failure. Donor relatedness was not associated with allograft outcomes. These results may inform pretransplant counseling and live donor selection. PLAIN-LANGUAGE SUMMARY: There are theoretical concerns that live-donor kidney transplants may be associated with increased risks of kidney disease recurrence and transplant failure due to unmeasurable shared genetic factors between the donor and the recipient. This study analyzed data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry and showed that, although disease type was associated with the risk of disease recurrence and transplant failure, donor relatedness did not impact transplant outcomes. These findings may inform pretransplant counseling and live donor selection.
引用
- Yu D, Malacova E, Hurst C, et al. Association of Primary Kidney Disease Type and Donor Relatedness With Live Donor Kidney Transplant Outcomes: An Analysis of ANZDATA. Am J Kidney Dis. 2023. PMID: 37385397. doi:10.1053/j.ajkd.2023.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。